Financhill
Back

AtriCure Vs. Repligen Industry Stock Comparison

Sell
36

ATRC
AtriCure

Last Price:
22.68
Seasonality Move:
-1.03%
Sell
43

RGEN
Repligen

Last Price:
126.47
Seasonality Move:
4.1%
Sell
36
AtriCure (ATRC) is a Sell

Is AtriCure a Buy, Sell or Hold?

  • The current AtriCure [ATRC] share price is $21.27. The Score for ATRC is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • ATRC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $123.15. The Score for RGEN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATRC Stock Price Chart

What is AtriCure's stock price today?

  • The AtriCure share price today is $21.27
    The current trend is relatively stagnant and ATRC is experiencing selling pressure, which indicates risk of future bearish movement.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $123.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing buying pressure, which is a positive indicator for future bullish movement.

ATRC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 44.95 Sell
Chaikin Money Flow: -334188 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.31 - 22.93) Sell
Bollinger Bands (100): (21.76 - 32.52) Sell

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -10.58 Sell
Relative Strength Index (14 RSI): 26.78 Sell
Chaikin Money Flow: 404437 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (128.14 - 158.7) Sell
Bollinger Bands (100): (150.47 - 196.23) Sell

ATRC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.6 Sell
20-day SMA: 21.99 Sell
50-day SMA: 22.41 Sell
200-day SMA: 32.29 Sell
8-day EMA: 21.88 Sell
20-day EMA: 22.03 Sell
50-day EMA: 23.38 Sell
200-day EMA: 31.26 Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 123.88 Sell
20-day SMA: 138.24 Sell
50-day SMA: 154.6 Sell
200-day SMA: 167.54 Sell
8-day EMA: 126.51 Sell
20-day EMA: 136.68 Sell
50-day EMA: 151.89 Sell
200-day EMA: 167.03 Sell

AtriCure Earnings Growth & ATRC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.02 per share, and an increase next year of $0.16 per share.

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.28 per share, and an increase next year of $0.56 per share.

AtriCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):